Clinical Trial Update: A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer [Phase 1]

View source ↗

Summary

Completed Phase 1 feasibility trial evaluating continuous adaptive [18F]FDG-PET-guided radiotherapy for head and neck squamous cell carcinoma. Sponsored by Univ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: University Hospital, Ghent | Conditions: Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED